South Africa is the world's most affected country by HIV (AIDS).
It was presented on November 27 by Health Minister Zweli Mkhize in KwaZulu-Natal, the province most affected by HIV. According to the latter, cited by the site eyewitnessnewsthis treatment has fewer side effects and patients tolerate it better. "The TLD is much cheaper" than previous treatments, "which will allow us to treat a larger number of people"said the minister. Eventually, the whole country is called upon to benefit from it.
"It's a highly effective treatment" allowing "a much faster virus removal" than others, told AFP Robert Matiru, director of operations ofUNITAIDwho financially supports the operation. Created in 2006 in New York at the UN conference on AIDS and chaired by the former French Minister of Health Marisol Touraine, this international organization centralizes the purchase of drug treatments to get better prices. Initially, Unitaid was financed by a tax on airline tickets instituted notably in France.
The TLD combines three anti-retroviral drugs, tenofovir disoproxil, lamivudine and dolutegravir, into a single tablet. This affordable treatment – US $ 75 per year per person – is expected to allow an estimated 5 million more people infected in South Africa to begin, and most importantly, to be able to continue to seek treatment.
South Africa has 7.7 million people living with HIV, 4.8 million of whom are receiving antiretroviral therapy. The highest prevalence rate (number of cases of a disease in a given population, according to Le Petit Robert) is among adults aged 15 to 49 years. 10% of AIDS deaths and 15% of new HIV infections worldwide occur in this country, according to Unitaid.